Evidence map›Paper›PMID 36012487›Full record

ArticleInternational journal of molecular sciences2022

Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins.

Victoria Catalán, Paula Domench, Javier Gómez-Ambrosi, Beatriz Ramírez, Sara Becerril, Amaia Mentxaka, Amaia Rodríguez, Víctor Valentí, Rafael Moncada, Jorge Baixauli and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Extracellular Matrix and Cancer: An Intricate Affair.International journal of molecular sciences · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Victoria CatalánMetabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-7513-7509
Paula DomenchMetabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Javier Gómez-AmbrosiMetabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-5601-1604
Beatriz RamírezMetabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Sara BecerrilMetabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-3441-1970
Amaia MentxakaMetabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Amaia RodríguezMetabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-2180-461X
Víctor ValentíCIBEROBN, Instituto de Salud Carlos III, 31008 Pamplona, Spain.
Rafael MoncadaCIBEROBN, Instituto de Salud Carlos III, 31008 Pamplona, Spain.
Jorge BaixauliDepartment of Surgery, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-0667-7827
Camilo SilvaCIBEROBN, Instituto de Salud Carlos III, 31008 Pamplona, Spain.
Javier EscaladaDepartment of Endocrinology & Nutrition, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-5877-9465
Gema FrühbeckMetabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-8305-7154
Instituto de Salud Carlos III · ESClinica Universidad de Navarra · ES

Funding

CIBEROBN 2022Instituto de Salud Carlos III PI19/00785Instituto de Salud Carlos III PI20/00080Instituto de Salud Carlos III PI20/00927
6 · The paper itself

Abstract

Dysfunctional adipose tissue (AT) in the context of obesity leads to chronic inflammation together with an altered extracellular matrix (ECM) remodelling, favouring cancer development and progression. Recently, the influence of dermatopontin (DPT) in AT remodelling and inflammation has been proposed. We aimed to evaluate the role of DPT in the development of obesity-associated colon cancer (CC). Samples obtained from 73 subjects [26 lean (LN) and 47 with obesity (OB)] were used in a case-control study. Enrolled subjects were further subclassified according to the established diagnostic protocol for CC (42 without CC and 31 with CC). In vitro studies in the adenocarcinoma HT-29 cell line were performed to analyse the impact of pro- and anti-inflammatory mediators on the transcript levels of DPT as well as the effect of DPT on ECM remodelling and inflammation. Although obesity increased (p < 0.05) the circulating levels of DPT, its concentrations were significantly decreased (p < 0.05) in patients with CC. Gene expression levels of DPT in the colon from patients with CC were downregulated and, oppositely, a tendency towards increased mRNA levels in visceral AT was found. We further showed that DPT expression levels in HT-29 cells were enhanced (p < 0.05) by inflammatory factors (LPS, TNF-α and TGF-β), whereas the anti-inflammatory IL-4 decreased (p < 0.05) its expression levels. We also demonstrated that DPT upregulated (p < 0.05) the mRNA of key molecules involved in ECM remodelling (COL1A1, COL5A3, TNC and VEGFA) whereas decorin (DCN) expression was downregulated (p < 0.05) in HT-29 cells. Finally, we revealed that the adipocyte-conditioned medium obtained from volunteers with OB enhanced (p < 0.01) the expression of DPT in HT-29 and Caco-2 cells. The decreased circulating and expression levels of DPT in the colon together with the tendency towards increased levels in visceral AT in patients with CC and its influence on the expression of ECM proteins suggest a possible role of DPT in the OB-associated CC.

Indexed as

Colonic NeoplasmsExtracellular Matrix ProteinsCaco-2 CellsCase-Control StudiesExtracellular MatrixHumansInflammationObesityRNA, MessengerExtracellular Matrix ProteinsRNA, Messengercolon cancerdermatopontinextracellular matrix remodellinginflammationobesity

Identifiers

PMID36012487
PMCPMC9408942
OpenAlexW4292261972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.